Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans.
Saved in:
| Title: | Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans. |
|---|---|
| Authors: | Borén J; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; Wallenberg Laboratory/Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden., Adiels M; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden., Björnson E; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden., Matikainen N; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Endocrinology, Abdominal Center, Helsinki University Hospital, Helsinki, Finland., Söderlund S; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Endocrinology, Abdominal Center, Helsinki University Hospital, Helsinki, Finland., Rämö J; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Henricsson M; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden., Ripatti P; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Ripatti S; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.; Department of Public Health, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Palotie A; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Mancina RM; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden., Ainola M; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Hakkarainen A; HUS Medical Imaging Center, Radiology, Helsinki University Hospital, University of Helsinki, Finland., Romeo S; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; Wallenberg Laboratory/Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden., Packard CJ; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Taskinen MR; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland. |
| Source: | Journal of internal medicine [J Intern Med] 2022 Feb; Vol. 291 (2), pp. 218-223. Date of Electronic Publication: 2021 Sep 26. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8904841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2796 (Electronic) Linking ISSN: 09546820 NLM ISO Abbreviation: J Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2796 |
|---|---|
| DOI: | 10.1111/joim.13375 |
